| Bariatric surgery: results in obesity and effects on metabolic parameters. | |
| | |
MedLine Citation:
|
PMID: 20975558 Owner: NLM Status: In-Process |
Abstract/OtherAbstract:
|
PURPOSE OF REVIEW: The use of bariatric surgery is increasing at an enormous rate in all countries but the indications for the operation on the basis of metabolic derangements are not clear as only one controlled randomized trial has been performed so far. Thus, it is not clear whether bariatric surgery should be performed on obese patients with long-standing type 2 diabetes or poorly controlled hypertension or hypertriglyceridemia. The mechanism for the immediate improvement in glucose tolerance after gastric bypass is not clear but is being actively investigated. RECENT FINDINGS: Gastric bypass appears to enhance glucagon-like peptide-1 production and suppress glucose-dependent insulinotropic polypeptide production. It appears that patients with type 2 diabetes and a greater BMI gain more benefit from the operation. SUMMARY: Bariatric surgery, particularly gastric bypass, has powerful and usually persistent effects on type 2 diabetes, dyslipidemia, and hypertension but randomized controlled trials with predefined metabolic entry criteria and planned comprehensive follow-up are required. |
| | |
Authors:
|
Peter M Clifton |
Related Documents
:
|
18581398 - Fast and optimized t1 mapping technique for the noninvasive quantification of gastric s... 10918538 - Effect of obesity and major weight reduction on gastric emptying. 8894468 - Gastric emptying in type 2 diabetes: quick or slow? 765178 - The effect of acute hyperglycemia on gastric emptying in man. 7785258 - Role of nitric oxide in insulin-dependent diabetes mellitus-related vascular complicati... 2210068 - Differences in lipoprotein subfraction composition and distribution between type i diab... |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Current opinion in lipidology Volume: 22 ISSN: 1473-6535 ISO Abbreviation: Curr. Opin. Lipidol. Publication Date: 2011 Feb |
Date Detail:
|
Created Date: 2011-01-14 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9010000 Medline TA: Curr Opin Lipidol Country: England |
Other Details:
|
Languages: eng Pagination: 1-5 Citation Subset: IM |
Affiliation:
|
Baker IDI Heart and Diabetes Institute, Adelaide, South Australia, Australia. peter.clifton@bakeridi.edu.au |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Advances in diagnosis and treatment of large granular lymphocyte syndrome.
Next Document: Central auditory disorders: toward a neuropsychology of auditory objects.